Innate Pharma S.A.
IPH.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€49,471 | -€7,570 | -€58,103 | -€52,809 |
| Dep. & Amort. | €1,994 | €5,091 | €45,405 | €4,596 |
| Deferred Tax | €0 | €0 | €0 | -€1,682 |
| Stock-Based Comp. | €0 | €4,256 | €4,249 | €2,617 |
| Change in WC | €39,162 | -€32,091 | -€12,502 | -€9,884 |
| Other Non-Cash | €1,419 | -€2,244 | €1,797 | -€1,295 |
| Operating Cash Flow | -€6,896 | -€32,558 | -€19,154 | -€58,457 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€391 | -€2,354 | -€1,122 | -€1,330 |
| Net Acquisitions | €0 | €0 | €0 | €7 |
| Inv. Purchases | €0 | €0 | €0 | €0 |
| Inv. Sales/Matur. | €9,590 | €22,768 | €3,000 | €0 |
| Other Inv. Act. | €1 | €217 | -€1 | €406 |
| Investing Cash Flow | €9,200 | €20,631 | €1,877 | -€917 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€8,936 | -€2,361 | -€2,026 | €26,631 |
| Stock Issued | €2,928 | €395 | €198 | €499 |
| Stock Repurch. | €0 | €0 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | €0 | €0 | €0 | -€312 |
| Financing Cash Flow | -€6,008 | -€1,966 | -€1,828 | €26,818 |
| Forex Effect | -€505 | €274 | -€428 | -€483 |
| Net Chg. in Cash | -€4,209 | -€13,620 | -€19,531 | -€33,036 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €70,605 | €84,225 | €103,756 | €136,792 |
| End Cash | €66,396 | €70,605 | €84,225 | €103,756 |
| Free Cash Flow | -€7,287 | -€34,909 | -€20,276 | -€59,787 |